Lawsuit for Investors in Keryx Biopharmaceuticals (NASDAQ:KERX) Filed
An investor, who purchased shares of Keryx Biopharmaceuticals (NASDAQ:KERX), filed a lawsuit in New York over alleged violations of Federal Securities Laws by Keryx Biopharmaceuticals.
View full press release